New insider activity at Elevance Health ( (ELV) ) has taken place on May 20, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Elevance Health’s Chief Accounting Officer and Controller, Ronald W. Penczek, has recently sold 1,531 shares of Elevance Health stock in a transaction valued at $617,192, according to the latest financial filing.
Spark’s Take on ELV Stock
According to Spark, TipRanks’ AI Analyst, ELV is a Outperform.
The score is driven primarily by solid fundamentals (scale, revenue durability, and improved TTM cash generation) and an attractive valuation (low P/E). Technicals are supportive but somewhat overheated, while the earnings outlook is constructive due to raised guidance and buybacks, tempered by the CMS accrual and continued Medicaid/margin pressures.
To see Spark’s full report on ELV stock, click here.
More about Elevance Health
YTD Price Performance: 15.46%
Average Trading Volume: 1,961,866
Technical Sentiment Signal: Buy
Current Market Cap: $85.58B